Ginger Supplementation May Improve Metabolic Parameters in Type 2 Diabetes: Study
A new study published in the journal of BMC Systematic Reviews showed that patients with type 2 diabetes may benefit from ginger supplementation in terms of metabolic markers.
Chronic hyperglycemia, insulin resistance, and a markedly increased risk of cardiovascular problems are the hallmarks of type 2 diabetes mellitus (T2DM), a growing worldwide health emergency. T2DM management necessitates an all-encompassing strategy that addresses related comorbidities, including dyslipidemia and hypertension, in addition to glycemic control.
The therapeutic potential of natural food supplements as adjuvant treatments is gaining attention, even while conventional medication continues to be the mainstay of treatment. Gingerols and shogaols, two bioactive chemicals found in ginger (Zingiber officinale), a popular spice and traditional botanical medicine, have attracted a lot of scientific interest. These phytochemicals have strong anti-inflammatory and antioxidant qualities that may alter metabolic processes.
Several randomized controlled trials have examined the therapeutic effectiveness of ginger in controlling diabetes indices during the last decade, with encouraging but occasionally contradictory findings. In order to thoroughly assess the overall effects of ginger supplementation on glycemic control, blood pressure, and lipid profiles in patients with type 2 diabetes and to provide evidence-based insights for clinical practice, this meta-analysis attempts to carefully integrate current data.
From the beginning until July 2, 2025, Scopus, PubMed, the Cochrane Library, and Web of Science were searched for randomized controlled studies comparing the effects of ginger with a placebo on blood pressure, lipid profiles, and glycemic indices in people with type 2 diabetes. Due to the significant heterogeneity, a random-effects model (DerSimonian-Laird) was used to pool the data.
This meta-analysis had 13 publications in total. Fasting blood sugar (FBS) (MD −16.27 mg/dl, 95% CI (−25.75, −6.80), I2 = 86.39%), hemoglobin A1c (HbA1c) (MD −0.41%, 95% CI (−0.63, −0.20), I2 = 92.09%), systolic blood pressure (MD −1.62, 95% CI (−3.01, −0.24), and triglyceride level (MD −17.10 mg/dL, 95% CI (−31.13, −3.07), I2 = 81.61%).
High-density lipoprotein cholesterol (HDL-C) levels also showed a statistically significant rise (MD 2.13 mg/dL, 95% CI (0.44, 3.82), I2 = 85.72%). However, the homeostasis model assessment for insulin resistance (HOMAIR), diastolic blood pressure, total cholesterol, low-density lipoprotein cholesterol (LDL-C), and body mass index (BMI) was not substantially altered by ginger therapy.
Overall, the results suggest ginger's potential as an adjuvant dietary intervention in the management of diabetes by showing improvements in glycemic control and other metabolic parameters. To validate its long-term effectiveness and ideal dose, further excellent research is required.
Source:
Chen, X., Cheng, S., & Zhang, D. (2026). Meta-analysis of the effects of ginger supplementation on glycemic control, blood pressure and lipid profile in patients with type 2 diabetes. Systematic Reviews. https://doi.org/10.1186/s13643-026-03251-5
